A citation-based method for searching scientific literature

Eve Maubec, Valérie Chaudru, Hamida Mohamdi, Christophe Blondel, Patricia Margaritte-Jeannin, Sébastien Forget, Eve Corda, Françoise Boitier, Stéphane Dalle, Pierre Vabres, Jean-Luc Perrot, Dominique Stoppa Lyonnet, Hélène Zattara, Sandrine Mansard, Florent Grange, Marie-Thérèse Leccia, Lynda Vincent-Fetita, Ludovic Martin, Béatrice Crickx, Pascal Joly, Luc Thomas, Brigitte Bressac-de Paillerets, Marie-Françoise Avril, Florence Demenais. J Am Acad Dermatol 2012
Times Cited: 19







List of co-cited articles
155 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
260
68

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
280
68

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
109
52

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
339
47

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
331
47

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
47

Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
444
42

Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma.
Lucia Pedace, Paola De Simone, Marco Castori, Isabella Sperduti, Vitaliano Silipo, Laura Eibenschutz, Carmelilia De Bernardo, Pierluigi Buccini, Elvira Moscarella, Chiara Panetta,[...]. Cancer Epidemiol 2011
19
36

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
224
36

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
P Ghiorzo, L Pastorino, P Queirolo, W Bruno, M G Tibiletti, S Nasti, V Andreotti, B Bressac-de Paillerets, G Bianchi Scarrà. Pigment Cell Melanoma Res 2013
65
36

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
V Nikolaou, X Kang, A Stratigos, H Gogas, M C Latorre, M Gabree, M Plaka, C N Njauw, K Kypreou, I Mirmigi,[...]. Br J Dermatol 2011
28
31


High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
249
31

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
L Pastorino, L Bonelli, P Ghiorzo, P Queirolo, L Battistuzzi, E Balleari, S Nasti, S Gargiulo, S Gliori, P Savoia,[...]. Pigment Cell Melanoma Res 2008
40
31

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
283
31

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
203
31

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
26

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Damiano Abeni, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
492
26

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Orietta Picconi, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
751
26

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
26

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
118
26


Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. J Natl Cancer Inst 2005
146
26

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia.
P Ghiorzo, P Ciotti, M Mantelli, A Heouaine, P Queirolo, M L Rainero, C Ferrari, P L Santi, R De Marchi, A Farris,[...]. Int J Cancer 1999
68
26

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
N Soufir, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets. Hum Mol Genet 1998
309
26

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Henry T Lynch, Randall E Brand, David Hogg, Carolyn A Deters, Ramon M Fusaro, Jane F Lynch, Ling Liu, Joseph Knezetic, Norman J Lassam, Michael Goggins,[...]. Cancer 2002
156
26

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.
Per Helsing, Dag Andre Nymoen, Sarah Ariansen, Solrun J Steine, Lovise Maehle, Steinar Aamdal, Frøydis Langmark, Mitchell Loeb, Lars A Akslen, Anders Molven,[...]. Genes Chromosomes Cancer 2008
35
26

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
613
26

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
26

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.
Mark Harland, Anne E Cust, Celia Badenas, Yu-Mei Chang, Elizabeth A Holland, Paula Aguilera, Joanne F Aitken, Bruce K Armstrong, Jennifer H Barrett, Cristina Carrera,[...]. Hered Cancer Clin Pract 2014
27
26

Genetic susceptibility in familial melanoma from northeastern Italy.
M T Landi, A M Goldstein, S Tsang, D Munroe, W Modi, M Ter-Minassian, R Steighner, M Dean, N Metheny, B Staats,[...]. J Med Genet 2004
36
26

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian,[...]. J Med Genet 2012
50
21

Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
Heather A McKenzie, Carina Fung, Therese M Becker, Mal Irvine, Graham J Mann, Richard F Kefford, Helen Rizos. Hum Mutat 2010
25
21

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
79
21

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder,[...]. J Natl Cancer Inst 2010
76
21

Role of the CDKN2A locus in patients with multiple primary melanomas.
Susana Puig, Josep Malvehy, Cèlia Badenas, Anna Ruiz, Dolores Jimenez, Francisco Cuellar, Antoni Azon, Urbá Gonzàlez, Teresa Castel, Antoni Campoy,[...]. J Clin Oncol 2005
106
21

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
488
21

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
467
21

CDKN2A mutations and melanoma risk in the Icelandic population.
A M Goldstein, S N Stacey, J H Olafsson, G F Jonsson, A Helgason, P Sulem, B Sigurgeirsson, K R Benediktsdottir, K Thorisdottir, R Ragnarsson,[...]. J Med Genet 2008
22
21

Clinical genetic testing for familial melanoma in Italy: a cooperative study.
William Bruno, Paola Ghiorzo, Linda Battistuzzi, Paolo A Ascierto, Monica Barile, Sara Gargiulo, Francesca Gensini, Sara Gliori, Michele Guida, Maurizio Lombardo,[...]. J Am Acad Dermatol 2009
34
21

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
83
21

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
302
21

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
William Bruno, Lorenza Pastorino, Paola Ghiorzo, Virginia Andreotti, Claudia Martinuzzi, Chiara Menin, Lisa Elefanti, Camilla Stagni, Antonella Vecchiato, Monica Rodolfo,[...]. J Am Acad Dermatol 2016
24
21

Update in genetic susceptibility in melanoma.
Miriam Potrony, Celia Badenas, Paula Aguilera, Joan Anton Puig-Butille, Cristina Carrera, Josep Malvehy, Susana Puig. Ann Transl Med 2015
99
21

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Hildur Helgadottir, Rainer Tuominen, Håkan Olsson, Johan Hansson, Veronica Höiom. J Am Acad Dermatol 2017
21
21


CDKN2A mutations in multiple primary melanomas.
J Monzon, L Liu, H Brill, A M Goldstein, M A Tucker, L From, J McLaughlin, D Hogg, N J Lassam. N Engl J Med 1998
196
15

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
Jasper I van der Rhee, Pieta Krijnen, Nelleke A Gruis, Femke A de Snoo, Hans F A Vasen, Hein Putter, Nicole A Kukutsch, Wilma Bergman. J Am Acad Dermatol 2011
30
15

Multiple primary melanoma revisited.
M Anne Blackwood, Robin Holmes, Marie Synnestvedt, Megan Young, Cicily George, Hannah Yang, David E Elder, Lynn M Schuchter, DuPont Guerry, Arupa Ganguly. Cancer 2002
56
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.